Clinical Trials Sponsored by Grupo Español de Síndromes Mielodisplásicos

Total 166 results

Grupo Espanol de Tumores Neuroendocrinos
Eisai Limited; Experior S.L.

Completed

Lenvatinib Efficacy in Metastatic Neuroendocrine Tumors (TALENT)

Neuroendocrine Tumors

Spain, Italy, Austria, United Kingdom
Grupo Espanol de Tumores Neuroendocrinos
Roche Pharma AG; Ipsen

Active, not recruiting

Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study (CABATEN)

Adenocarcinoma | Neuroendocrine Tumor | Pheochromocytoma | Paraganglioma | Anaplastic Thyroid Cancer

Spain
Grupo Espanol de trasplantes hematopoyeticos y...
GlaxoSmithKline

Completed

Ofatumumab as Part of Reduced Intensity Conditioning (RIC) Regimen for Patients With High Risk Chronic Lymphocytic Leukemia (CLL) Undergoing Allogeneic Hematopoietic Cell Transplantation

Chronic Lymphocytic Leukemia

Spain
Grupo Espanol de Trabajo en Enfermedad de Crohn...

Recruiting

Impact of Therapeutic Intervention on Quality of Life in Patients With Ulcerative Colitis (CAVI_CU)

IBD-Inflammatory Bowel Disease | UC - Ulcerative Colitis

Spain
Grupo Espanol de Trabajo en Enfermedad de Crohn...

Recruiting

Prospective Multicenter Randomized Comparative Study of the Treatment of de Novo Stenosis in Chron's Disease. (ENDOCIR)

Crohn Disease

Spain
Grupo Espanol de Trabajo en Enfermedad de Crohn...

Active, not recruiting

Impact of Telemonitoring in the Management of Complex IBD in Spain: M-TECCU (M-TECCU)

Crohn's Disease | Ulcerative Colitis | Telemedicine | Inflammatory Bowel Disease

Spain
Grupo Espanol de Trabajo en Enfermedad de Crohn...

Unknown

Comparative Prospective Multicenter Randomized Study of Endoscopic Treatment of Stenosis in Crohn´s Disease (PROTDILAT)

Crohn's Disease | Chronic Inflammation | Stenosis

Spain
Grupo Español de Rehabilitación Multimodal
Universidad de Zaragoza; Aragon Health Science Institute

Recruiting

Microporous Polysaccharide Hemospheres (MPH) Improving Outcome After Rectal Surgery (EPHAS)

Postoperative Sepsis

Spain
Grupo Español de Investigación en Cáncer de Ovario
AstraZeneca; Apices Soluciones S.L.

Completed

Olaparib After Response to Trabectedin-pegylated Liposomal Doxorubicin in Recurrent Ovarian Carcinoma

Ovarian Cancer

Spain
PETHEMA Foundation
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea

Recruiting

Treatment of Mature B-ALL and Burkitt Lymphoma (BL) in Adult Patients. BURKIMAB-14.

Mature B-Cell Leukemia Burkitt Type | Burkitt Lymphoma (BL) | Unclassifiable Lymphoma Between DCBL and BL

Spain
Grupo Espanol de Trabajo en Enfermedad de Crohn...

Not yet recruiting

Immunological Characteristics of Preclinical IBD(EARLY) (EARLY)

Crohn Disease | Ulcerative Colitis | IBD

Spain
Grupo Espanol de Trabajo en Enfermedad de Crohn...

Completed

Endovenous Corticosteroid Pulses in Moderate Ulcerative Colitis (CECUM)

Ulcerative Colitis

Spain
Grupo Espanol de Trabajo en Enfermedad de Crohn...

Completed

A Prospective Study on the Incidence and Risk Factors Related to Infection in Patients With Inflammatory Bowel Disease (INFEII)

Inflammatory Bowel Diseases

Spain
Grupo Espanol de Trabajo en Enfermedad de Crohn...

Terminated

Efficacy Study of Granulocytapheresis Plus Steroids vs Steroids Alone in Active Steroid Dependant Ulcerative Colitis (ATICCA)

Ulcerative Colitis

Spain, Portugal, Austria, Italy, Germany
Grupo Español de Linfomas y Transplante Autólogo...
Janssen-Cilag, S.A.

Completed

Efficacy/Safety Study of R-CHOP vs Bortezomib-R-CAP for Young Patients With Diffuse Large B-cell Lymphoma With Poor IPI.

Diffuse, Large B-Cell, Lymphoma

Spain
Grupo Español de Linfomas y Transplante Autólogo...
Janssen-Cilag, S.A.

Active, not recruiting

Ibrutinib in Combination With Rituximab in Patients With Indolent Clinical Forms of MCL

Mantle Cell Lymphoma

Spain
Grupo Español de Linfomas y Transplante Autólogo...
Janssen-Cilag, S.A.

Unknown

Ibrutinib in Patients With Refractory/Relapsed Non-GCB Diffuse Large B-cell Lymphoma Non-candidates to Autologous Stem Cell Transplantation

Diffuse Large B-Cell Lymphoma

Spain
PETHEMA Foundation
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea; GELCAB

Completed

ZAR2007: R-CHOP in Folicular Lymphoma Patients no Treated Previously. Consolidation With 90Y Ibritumomab Tiuxetan (Zevalin®) Versus Maintenance Treatment With Rituximab (MabThera®)

Lymphoma

Spain
Grupo Español de Linfomas y Transplante Autólogo...
Millennium Pharmaceuticals, Inc.

Completed

Brentuximab Vedotin in Pre-transplant Induction and Consolidation for Relapsed or Refractory Hodgkin Lymphoma

CLASSICAL HODGKIN LYMPHOMA

Spain
Grupo Español de Investigación en Cáncer de Ovario
Apices Soluciones S.L.; TESARO/GSK

Active, not recruiting

TSR-042 as Maintenance Therapy for Patients With High-risk Locally Advanced Cervical Cancer After Chemo-radiation (ATOMICC) (ATOMICC)

Cervical Cancer | Advanced Cancer

Spain, Turkey
Grupo Español de Tratamiento de Tumores de Cabeza...
Amgen; Trial Form Support S.L.

Completed

Study of the Combination of Panitumumab With Paclitaxel as First-line Treatment of Subjects With Head and Neck Cancer (VECTITAX)

Head and Neck Cancer

Spain
Grupo de Trabajo de Enfermedades Autoinmunes Sistémicas...

Not yet recruiting

Belimumab in Patients With Systemic Lupus Erythematosus (BeliLES)

Systemic Lupus Erythematosus

Spain
Grupo Español de Rehabilitación Multimodal
Instituto de Salud Carlos III; Instituto de Investigación Sanitaria Aragón

Recruiting

Long-term Enlarged Survival After an Enhanced Recovery Protocol (LESAS). (LESAS)

Major Surgery

Spain
Grupo Español de Rehabilitación Multimodal
Instituto Aragones de Ciencias de la Salud; Instituto de Investigación Sanitaria...

Recruiting

Implementation of Enhanced Recovery Protocol in Spain (IMPRICA)

Major Surgery

Spain
Grupo Español de Tratamiento de Tumores de Cabeza...
Bristol-Myers Squibb; Apices Soluciones S.L.

Active, not recruiting

Study to Assess the Efficacy and Safety of Nivolumab in Combination With Paclitaxel in Subjects With Head and Neck Cancer Unable for Cisplatin-based Chemotherapy (NIVOTAX) (NIVOTAX)

Recurrent Head and Neck Squamous Cell Carcinoma | Head and Neck Cancer Stage IV

Spain
Grupo Español de Tratamiento de Tumores de Cabeza...
Merck Sharp & Dohme LLC; Pivotal S.L.

Terminated

Paclitaxel vs Paclitaxel + Cetuximab in Recurrent - Metastatic Head & Neck Carcinoma After Failure of a 1º Chemotherapy (EXTAX)

Head and Neck Cancer
Grupo Español de Tumores Huérfanos e Infrecuentes
Astellas Pharma Inc; Apices Soluciones S.L.

Completed

Enzalutamide in Metastatic or Advanced Non-resectable Granulosa Cell Ovarian Tumors: GREKO III Study (GREKO III)

Ovarian Cancer

Spain
Italian Sarcoma Group
French Sarcoma Group; Grupo Espanol de Investigacion en Sarcomas

Active, not recruiting

Localized High-Risk Soft Tissue Sarcomas Of The Extremities And Trunk Wall In Adults: An Integrating Approach Comprising Standard Vs Histotype-Tailored Neoadjuvant Chemotherapy

Localized High-risk Soft Tissue Sarcomas of the Extremities and Trunk Wall in Adults

Spain, Italy
Grupo Espanol de Investigacion en Sarcomas
Centre Leon Berard; Italian Sarcoma Group

Recruiting

Trabectedin Plus Radiotherapy in Soft Tissue Sarcoma Patients (TRASTS)

Sarcoma, Soft Tissue | Leiomyosarcoma | Liposarcoma | Liposarcoma, Myxoid | Pleomorphic Liposarcoma

France, Spain, Italy
Grupo Espanol de Tumores Neuroendocrinos
Novartis Pharmaceuticals; European Neuroendocrine Tumor Society; Kantar Health

Completed

Efficacy and Safety of Everolimus and (STZ-5FU) Given One Upfront the Other Upon Progression in Advanced Pancreatic Neuroendocrine Tumor (pNET) (SEQTOR)

Neuroendocrine Tumors

Spain, United Kingdom, Denmark, France, Netherlands, Germany, Italy, Sweden
Grupo Español de Linfomas y Transplante Autólogo...
Institut d'Investigacions Biomèdiques August Pi i Sunyer

Terminated

DETERMINATION OF THE CELL OF ORIGIN (COO) in LDCGB (GELTAMO-COO)

CCO

Spain
Groupe Oncologie Radiotherapie Tete et Cou
AIO-Studien-gGmbH; Grupo Español de Tratamiento de Tumores de Cabeza y Cuello

Completed

Platinum-Cetuximab Combined With Docetaxel or With 5FU in Patients With Recurrent/Metastatic HNSCC (TPExtreme)

Head and Neck Squamous Cell Carcinoma

France, Germany, Spain
Grupo Español de Investigación en Neurooncología
Tilray; Medical Cannabis Bike Tour; Voices Against Brain Cancer

Recruiting

TN-TC11G (THC+CBD) Combination With Temozolomide and Radiotherapy in Patients With Newly-diagnosed Glioblastoma (GEINOCANN)

Glioblastoma

Spain
Grupo Espanol de Trabajo en Enfermedad de Crohn...
Abbott; TFS Trial Form Support

Terminated

Assessment of Mucosal Activity to Improve the Prognosis of Patients With Crohn's Disease Treated With Immunosuppressants (ADACAL)

Crohn's Disease | Mucosal Inflammation

Spain, France, Belgium
Fundación Instituto de Estudios de Ciencias de...
Instituto de Investigación Biomédica de Salamanca; Grupo Español de Rehabilitación...

Terminated

Clinical Trial With Quetiapine Prophylaxis Postoperative Delirium in High Risk Surgical Patients

Postoperative Delirium

Spain
Grupo Espanol de Trabajo en Enfermedad de Crohn...
Effice Servicios Para la Investigacion S.L.

Completed

Adalimumab on Preventing Post-chirurgic Recurrence on Crohn´s Disease (APPRECIA)

Crohn´s Disease

Spain
NCIC Clinical Trials Group
UNICANCER; Grupo Espanol de Investigacion del Cancer de Mama

Completed

Exemestane in Preventing Cancer in Postmenopausal Women at Increased Risk of Developing Breast Cancer (ExCel)

Breast Cancer

United States, France, Canada, Puerto Rico
Grupo Español de Linfomas y Transplante Autólogo...
Celgene Corporation; Dynamic Science S.L.; Thermo Fisher Scientific, Inc

Completed

Clinical Trial to Determinate Dose, Security and Efficacy or Lenalidomide and Rituximab (LR)-ESHAP in Patients With Diffuse Large B-cell Lymphoma

Diffuse Large B-cell Lymphoma

Spain
Grupo Espanol de Trabajo en Enfermedad de Crohn...
Spanish Agency of Medicines and Health Products

Recruiting

Safety of IBD Drugs During Pregnancy and Breastfeeding: Mothers and Babies' Outcomes (DUMBO Registry)

Inflammatory Bowel Diseases | Pregnancy

Spain
Grupo Español de Tratamiento de Tumores de Cabeza...
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt...

Completed

Cetuximab Plus Paclitaxel as First Line for Recurrent and/or Metastatic SCCHN: Real World Data.

Squamous Cell Carcinoma of the Head and Neck

Spain
AbbVie
NSABP Foundation Inc; German Breast Group; US Oncology Research; Grupo Espanol...

Completed

A Study Evaluating Safety and Efficacy of the Addition of ABT-888 Plus Carboplatin Versus the Addition of Carboplatin to Standard Chemotherapy Versus Standard Chemotherapy in Subjects With Early Stage Triple Negative Breast Cancer

Triple Negative Breast Cancer

United States, Australia, Belgium, Canada, Czechia, France, Germany, Hungary, Italy, Korea, Republic of, Netherlands, Russian Federation, Spain, Taiwan, United Kingdom
AGO Study Group
Cancer Research UK; ARCAGY/ GINECO GROUP; Grupo Español de Investigación en Cáncer... and other collaborators

Completed

Study Comparing Tumor Debulking Surgery Versus Chemotherapy Alone in Recurrent Platinum-Sensitive Ovarian Cancer (DESKTOPIII)

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity Cancer

Spain, France, Denmark, Belgium, Germany, Austria, China, Italy, Korea, Republic of, Norway, Sweden, United Kingdom
Javier P. Gisbert
Grupo Español de trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU)

Completed

An Epidemiological Study of the Incidence of Inflammatory Bowel Disease in Spain (INCIDENCIA)

Inflammatory Bowel Disease

Spain
Instituto de Investigación Hospital Universitario...
Hospital Universitario La Paz; Proyecto Ictus- Grupo Estudio Enfermedades CerebroVasculares...

Recruiting

Atrial Imaging and Cardiac Rhythm In Embolic Stroke (ARIES)

Atrial Fibrillation | Stroke, Ischemic | Cryptogenic Stroke | Atrial Dilatation

Spain
Canadian Cancer Trials Group
National Cancer Institute (NCI); Cancer Research UK; Grupo Español de Investigación... and other collaborators

Completed

Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity Cancer | Metastatic Cancer

Canada, Spain, United States, United Kingdom
Fundación Pública Andaluza para la gestión de la...
Grupo Espanol de trasplantes hematopoyeticos y terapia celular; Instituto de...

Completed

Optimization of Antibiotic Treatment in Hematopoietic Stem Cell Receptors (Optimbioma)

Hematopoietic Stem Cell Transplantation | Graft Versus Host Disease

Spain
Centro Nacional de Investigaciones Oncologicas...
M.D. Anderson Cancer Center; Hospital Universitari de Bellvitge; Grupo Espanol... and other collaborators

Completed

Neoadjuvant Paclitaxel Versus BIBF 1120 Priming Followed by BIBF 1120 Plus Paclitaxel in Early HER-2 Negative Breast Cancer With Proteomic and Dynamic Imaging Correlates

Breast Cancer

Spain
European Organisation for Research and Treatment...
UNICANCER; Grupo Espanol de Investigacion en Sarcomas; Italian Sarcoma Group

Completed

Imatinib Mesylate or Observation Only in Treating Patients Who Have Undergone Surgery for Localized Gastrointestinal Stromal Tumor

Gastrointestinal Stromal Tumor

France, Australia, United Kingdom, Germany, Denmark, Spain
The Lymphoma Academic Research Organisation
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea; Swiss Group... and other collaborators

Recruiting

Study of Mosunetuzumab Plus Lenalidomide Compared to Anti-CD20 Anti-body + Chemotherapy in Follicular Lymphoma FLIPI2-5 (MorningLyte)

Follicular Lymphoma

Belgium, France, Germany, Portugal, Spain
NCIC Clinical Trials Group
European Organisation for Research and Treatment of Cancer - EORTC; Grupo Español...

Completed

Combination Chemotherapy Regimens in Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer

Ovarian Cancer | Fallopian Tube Cancer | Peritoneal Cavity Cancer

Canada

Clinical Trials Sponsored by Grupo Español de Síndromes Mielodisplásicos

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ecuador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations